Aeolus Pharmaceuticals Inc. (AOLS)
|Net Income (ttm)||-4.09M|
|Trading Day||July 28|
|Day's Range||0.0040 - 0.0040|
|52-Week Range||0.0010 - 0.0200|
There are no news available yet.
Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. The company develops a class of catalytic antioxidant compounds as medical countermeasures against nuclear, radiological, and chemical weapons, as well as for diseases and disorders of the respiratory system, central nervous system, and oncology. Its lead compound includes AEOL 10150 that has completed two Phase I clinical trials, which ... [Read more...]
Drug Manufacturers-Specialty & Generic
|IPO Date |
Feb 1, 1996
|Stock Exchange |
|Ticker Symbol |
In 2016, AOLS's revenue was $2.08 million, a decrease of -33.27% compared to the previous year's $3.11 million. Losses were -$3.56 million, 35.4% more than in 2015.